Caris Life Sciences, Inc.
Ownership
Ownership Structure
Who owns Caris Life Sciences, Inc. (CAI)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 47.7% of the shares are freely tradable; institutional investors hold 56.7%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| FMR Inc | 10.94 | 30,923,878 | +0.4 | 06/30/2026 |
| J. H. Whitney Equity Partners VI, LLC | 3.98 | 11,256,615 | -38.3 | 06/30/2026 |
| Coatue Management LLC | 3.47 | 9,819,992 | +0.0 | 06/30/2026 |
| BRAIDWELL LP | 2.92 | 8,256,032 | +3.1 | 06/30/2026 |
| Sixth Street Partners Management Company, L.P. | 2.59 | 7,327,041 | -49.1 | 06/30/2026 |
| PointState Capital LP | 2.42 | 6,828,835 | -7.2 | 06/30/2026 |
| JPMorgan Chase & Co | 2.32 | 6,558,514 | +89.5 | 06/30/2026 |
| BlackRock Inc | 1.96 | 5,536,798 | +14.0 | 06/30/2026 |
| T. Rowe Price Investment Management,Inc. | 1.80 | 5,079,141 | -9.1 | 06/30/2026 |
| Vanguard Portfolio Management, LLC | 1.71 | 4,844,431 | +28.9 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Spetzler David Baxley | President | 1,182,871 | 39,271,317 $ | Sep 4, 2026 | direct |
| Halbert Jon | Director | 836,411 | 27,768,845 $ | May 15, 2026 | both |
| Johansen Laura I | Director | 343,897 | 11,417,380 $ | Aug 14, 2026 | direct |
| Brille Brian J | See Remarks | 230,303 | 7,646,060 $ | Sep 17, 2026 | direct |
| Denton John Russel | See Remarks | 174,855 | 5,805,186 $ | Sep 22, 2026 | direct |
| Phillips T Danny | Director | 133,060 | 4,417,592 $ | Aug 14, 2026 | direct |
| Vacirca Jeff L | Director | 62,863 | 2,087,052 $ | Aug 14, 2026 | direct |
| Fredrickson David Paul | Director | 31,813 | 1,056,192 $ | Aug 14, 2026 | direct |
| Minor Lloyd | Director | 31,813 | 1,056,192 $ | Aug 14, 2026 | direct |
| Gilliam Joseph E | Director | 29,321 | 973,457 $ | Aug 14, 2026 | direct |
| Castleman Peter M | Director | 29,321 | 973,457 $ | Aug 14, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 22, 2026 | Denton John Russel | See Remarks | Sell | 7,500 | 31.82 | 238,626 |
| Sep 17, 2026 | Brille Brian J | See Remarks | Sell | 400,000 | 30.33 | 12,132,080 |
| Sep 17, 2026 | Brille Brian J | See Remarks | Other | 400,000 | 2.44 | 976,000 |
| Sep 4, 2026 | Spetzler David Baxley | President | Sell | 119,212 | 24.76 | 2,951,117 |
| Sep 4, 2026 | Spetzler David Baxley | President | Other | 250,000 | 2.44 | 610,000 |
| Sep 3, 2026 | Spetzler David Baxley | President | Sell | 84,900 | 25.32 | 2,149,676 |
| Sep 3, 2026 | Spetzler David Baxley | President | Sell | 393,100 | 24.76 | 9,733,313 |
| Sep 3, 2026 | Spetzler David Baxley | President | Other | 1,000,000 | 2.44 | 2,440,000 |
| Aug 14, 2026 | Fredrickson David Paul | Director | Other | 13,192 | 0.00 | – |
| Aug 14, 2026 | Minor Lloyd | Director | Other | 13,192 | 0.00 | – |
| Aug 14, 2026 | Vacirca Jeff L | Director | Other | 13,192 | 0.00 | – |
| Aug 14, 2026 | Gilliam Joseph E | Director | Other | 13,192 | 0.00 | – |
| Aug 14, 2026 | Phillips T Danny | Director | Other | 13,192 | 0.00 | – |
| Aug 14, 2026 | Castleman Peter M | Director | Other | 13,192 | 0.00 | – |
| Aug 14, 2026 | Johansen Laura I | Director | Other | 13,192 | 0.00 | – |
| Aug 14, 2026 | Halbert Jon | Director | Other | 13,192 | 0.00 | – |
| May 15, 2026 | Halbert Jon | Director | Buy | 68,000 | 14.56 | 990,080 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.